POS-416 TREATING HCV INFECTION IN CHRONIC KIDNEY DISEASE IN DEVELOPING COUNTRY: OUR EXPERIENCE WITH LIMITED RESOURCES

POS-416 TREATING HCV INFECTION IN CHRONIC KIDNEY DISEASE IN DEVELOPING COUNTRY: OUR EXPERIENCE WITH LIMITED RESOURCES

Bibliographic Details
Main Authors:	S. Sharma, N. Sharma, K. Sharma
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024921005842

Similar Items

Current Management Strategies of Chronic Kidney Disease in Resource-Limited Countries
by: Ameh OI, et al.
Published: (2020-10-01)

THE DAAS TREATMENT OF CHRONIC HCV INFECTION AND THE LIVER FIBROSIS EVOLUTION DURING TREATMENT: OUR EXPERIENCE
by: Andreea Rădășan, et al.
Published: (2016-09-01)

Sharing our Experience
by: Sudha Sharma
Published: (2013-04-01)

A prospective study of daclatasvir and sofosbuvir in chronic HCV-infected kidney transplant recipients
by: Michael Duerr, et al.
Published: (2019-02-01)

HCV-Specific T Cell Responses During and After Chronic HCV Infection
by: Hendrik Luxenburger, et al.
Published: (2018-11-01)

Sofosbuvir in therapy of chronic HCV-infection
by: C. S. Pavlov, et al.
Published: (2016-12-01)

Increased mortality in chronic HCV infection
by: Ezequiel Ridruejo, MD
Published: (2012-11-01)

Indications for treatment in chronic HCV infection
by: Milagros Dávalos Moscol
Published: (2010-01-01)

Infection control practice in countries with limited resources
by: Alp Emine, et al.
Published: (2011-10-01)

POS-213 INCIDENCE OF ACUTE KIDNEY INJURY IN PATIENTS WITH CHRONIC LIVER DISEASE AND ITS IMPACT ON CLINICAL OUTCOME
by: S.K. Sharma, et al.
Published: (2021-04-01)

Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.
by: Trevor J Morin, et al.
Published: (2012-01-01)

POS-035 SEPSIS AS AN ETIOLOGY AND COMPLICATION IN COMMUNITY-ACQUIRED ACUTE KIDNEY INJURY IN LOW RESOURCE SETTING
by: P. KHATIWADA, et al.
Published: (2021-04-01)

P4.16 EFFECT OF DENERVATION ON VISCOELASTIC PROPERTIES OF LARGE ARTERIES IN POLYCYSTIC KIDNEY DISEASE RATS
by: Z. Kouchaki, et al.
Published: (2013-11-01)

HCV-infected Renal Transplant Recipients: Our Experience before the Availability of New Antiviral Drugs
by: AR Fernandes, et al.
Published: (2017-04-01)

A Study on the HBV and the HCV Infections in Female Sex Workers and their Co-Infection with HIV
by: Desai Praseeda S, et al.
Published: (2013-02-01)

Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection
by: Calza Leonardo, et al.
Published: (2010-05-01)

Reversal of T Cell Exhaustion in Chronic HCV Infection
by: Sylwia Osuch, et al.
Published: (2020-07-01)

Treatment of Chronic HCV Infection in Special Populations
Published: (2006-04-01)

POS-811 IMPACT OF CORONAVIRUS INFECTION ON THE COURSE OF CHRONIC KIDNEY DISEASE
by: O. SHEVCHENKO
Published: (2021-04-01)

Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan
by: Ahmad Habib, et al.
Published: (2011-10-01)

A Study on the Biochemical and the Morphological Changes in the Liver in Renal Transplant Recipients with an Evidence of the HBV and the HCV Infections
by: Sonia Sharma, et al.
Published: (2013-01-01)

POS-745 SCREENING FOR APOL1 RISK VARIANTS IN POTENTIAL LIVING KIDNEY DONORS OF AFRICAN DESCENT IN RESOURCE-LIMITED COUNTRIES: AN INITIAL EXPERIENCE IN ANTIGUA/BARBUDA AND NIGERIA
by: J. LANG, et al.
Published: (2021-04-01)

Laying the ground for research of interstitial lung disease in our country: ILD India registry
by: Virendra Singh, et al.
Published: (2014-01-01)

Level of health behaviours of HCV infected patients treated with dialysotherapy
by: Lidia Sierpińska, et al.
Published: (2019-12-01)

Acute Kidney Injury Risk Assessment: Differences and Similarities Between Resource-Limited and Resource-Rich Countries
by: Kianoush Kashani, et al.
Published: (2017-07-01)

HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?
by: Giuseppe Bruno, et al.
Published: (2017-09-01)

Updated View on Kidney Transplant from HCV-Infected Donors and DAAs
by: Fabrizio Fabrizi, et al.
Published: (2021-04-01)

Chronic HCV infection: An internist’s opinion (Part 2)
by: M L Zubkin, et al.
Published: (2016-11-01)

THE CYTOKINE IP-10 IN CHRONIC HBV AND HCV INFECTION
by: Nina S. Nikolova, et al.
Published: (2013-08-01)

Natural killer cell function in chronic HCV infection
by: Collister, Mark
Published: (2013)

Orbital Pseudotumor as an Extrahepatic Complication of Chronic HCV Infection
by: Owen Huang, et al.
Published: (2018-01-01)

Natural killer cell function in chronic HCV infection
by: Collister, Mark
Published: (2013)

Chronic HCV Infection: Clinical Advances and Eradication Perspectives
Published: (2022)

Treated as ‘niggers’ in our own country: lived experiences of Rastafarians in the Democratic Malawi
by: Steward Maganga, et al.
Published: (2020-10-01)

Lower Rates Of Naturally Occurring Resistance-Associated Substitutions (RASs) In Hepatitis C Virus (HCV)-Infected Chronic Kidney Disease (CKD) Patients Than In HCV-Infected Patients With Only Liver Disease
by: Gupta E, et al.
Published: (2019-11-01)

Tyrosine 416 is phosphorylated in the closed, repressed conformation of c-Src.
by: Sevgi Irtegun, et al.
Published: (2013-01-01)

Trends of 9,416 multidrug-resistant Gram-negative bacteria
by: Viviane Decicera Colombo Oliveira, et al.
Published: (2015-06-01)

Fundamentos En Inteligencia De Negocios - SI416 201801
by: Universidad Peruana de Ciencias Aplicadas (UPC)
Published: (2018)

Mikołaj Grynberg, Księga wyjścia, Czarne, Wołowiec 2018, s. 416
by: Sławomir Jacek Żurek
Published: (2018-12-01)

Nutritional state of HCV-infected individuals examined and treated in outpatient clinic
by: C. M. Carreira
Published: (2005-03-01)